Search for: "Wyeth Pharmaceuticals" Results 461 - 480 of 976
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jun 2010, 11:46 am by Joe Consumer
Last Friday, a Javelin Pharmaceuticals, Inc. news release on Business Wire announced that the U.S. [read post]
16 Jun 2010, 10:06 pm by Walter Olson
” [Abnormal Use, earlier] Tags: failure to warn, pharmaceuticals Related posts Mirapex jackpot justice – literally (22) FDA overwarning (0) Wyeth v. [read post]
3 Jun 2010, 1:37 pm by Bexis
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004); White v. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva,… [read post]
2 Jun 2010, 3:02 pm by Carey, Danis & Lowe, L.L.C.
One of the most difficult matters in deciding pharmaceutical cases is determining where fault lies in the production of generic medications. [read post]
2 Jun 2010, 6:29 am by John J. Cord
He settled with the hospital on the heparin overdose of his children, but now he’s going after the pharmaceutical company, Baxter Healthcare Corp. [read post]
30 May 2010, 12:59 pm
Reuben Guttman, Director at Grant and Eisenhofer and one of the foremost whistleblower attorneys in the country, is lead counsel in a stunning whistleblower suit against one of the largest pharmaceutical companies-- Wyeth, now owned by Pfizer. [read post]
30 May 2010, 11:59 am by Williams Oinonen LLC
Reuben Guttman, Director at Grant and Eisenhofer and one of the foremost whistleblower attorneys in the country, is lead counsel in a stunning whistleblower suit against one of the largest pharmaceutical companies-- Wyeth, now owned by Pfizer. [read post]
28 May 2010, 10:04 am by Walter Olson
Tags: pharmaceuticals, qui tam, securities litigation, whistleblowers Related posts Vioxx settlement: February 8 update (32) Lucrative world of IRS informant bounties (6) Wyeth v. [read post]
27 May 2010, 3:40 pm by Bexis
Wyeth-Ayerst Laboratories, 1996 WL 784566 (N.D. [read post]
16 May 2010, 6:01 pm by Steve McConnell
" Given that language, this case might be ripe for the sort of preemption defense that survives Wyeth v. [read post]
13 May 2010, 12:27 pm by Bexis
Wyeth, Inc., 2010 WL 450351 (W.D. [read post]